View contact record, Full name: Martina Buonanno
CNR Ibb | back to homepage
CNR Ibb | back to homepage
▲NavBar
Advanced search Ricerca avanzata▼
Query Ricerca:      Extended Estesa  
    
Photo Foto
Name NomeMartina Buonanno
AreaResearch&Development Ricerca e Sviluppo
Position QualificaTemporary Researcher Ricercatore Temporaneo
Work site SedeNaples-Mezzocannone Napoli-Mezzocannone
Address IndirizzoVia Mezzocannone 16, 80134 Naples - Italy Napoli - Italia
E-mailmartina.buonannocnr.it
▼    Structure and function of proteins involved in physio-pathologic processes Struttura e funzione di proteine coinvolte in processi fisiopatologici
▼    Carbonic Anhydrase IX as target for the development of new anti-tumour drugs L’Anidrasi Carbonica IX come target per lo sviluppo di nuovi farmaci antitumorali
▼    Biomolecole in grado di modulare l’angiogenesi VEGF-dipendente Biomolecules able to modulate the VEGF-dependent angiogenesis
▼    A multi-targeting approach to fight COVID-19 Un approccio multi-targeting per combattere COVID-19
▼    Galectins: Structure, function and therapeutic potential inhibitors Galectine: struttura, funzione e potenziali inibitori terapeutici
▼    Caratterizzazione della famiglia proteica delle KCTD: fattori chiave in diversi processi biologici Characterization of the KCTD protein family: key factors in several biological processes
▼    Sintesi chimica e modificazione di proteine per applicazioni in campo biomedico Chemical protein synthesis and modification for biomedical applications
▼    Protein-Protein-Interaction network–disease relationship, pathogenicity and therapeutic perspectives Relazione tra malattia e alterate interazioni proteina-proteina: patogenicità e prospettive terapeutiche
▼    Biomolecular NMR: structural studies of proteins and peptides and drug discovery applications Risonanza magnetica nucleare biomolecolare: studi strutturali di proteine e peptidi e applicazioni per il “drug discovery”
▼    Structural characterization of the porphyrins/proteasome interaction Caratterizzazione strutturale dell’interazione porfirine/proteosoma
▼    Axl and Gas6 targeting for therapeutic and diagnostic applications Molecole che bersagliano Axl e Gas6 per applicazioni a scopo terapeutico e diagnostico
▼    Drug discovery by mirror-image phage display Drug discovery attraverso l’impiego della tecnologia del mirror-image phage display
▼    Analysis of Sam domain druggability through computational and experimental studies I domini Sam come bersagli farmacologici: studi computazionali e sperimentali
▼    Targeting Sam-Sam interactions mediated by EphA2 receptor: design and evaluation of peptide inhibitors Progettazione e validazione di peptidi inibitori delle interazioni Sam-Sam mediate dal recettore EphA2
▼    Synthesis of small molecules, modified peptides and nucleobase-decorated peptides. Spectroscopic and computational investigation on the potential of natural product in biomedicine. Nucleic acid and protein binding studies Sintesi di small molecules, peptidi modificati e peptidi decorati con nucleobasi. Valutazione spettroscopica e computazionale del potenziale di prodotti naturali in biomedicina. Studi di interazione molecolare con acidi nucleici e proteine
▼    Biochemical and functional characterization of intrinsically disordered proteins (IDPs) in human diseases Caratterizzazione biochimica e funzionale di proteine intrinsecamente disordinate e loro ruolo nelle malattie umane
▼    Biochemical and functional characterization of Protein-Protein and DNA-protein Interaction networks in physio/pathological events Caratterizzazione biochimica e funzionale di interazioni proteina-proteina e DNA-proteina in eventi fisio/patologici
▼    Biochemical and structural insights on Chromatin Assembly Factor 1 in physio/pathological events Studi biochimici e molecolari sul Fattore di Assemblaggio della Cromatina 1 coinvolta in eventi fisiopatologici
▼    Targeting Of Protein-Protein Interactions For Therapeutic Purposes Targeting delle interazioni proteina-proteina per scopi terapeutici
▼    Cancer Diseases Malattie Neoplastiche
▼    Gadd45 beta and its implication in chronic inflammation
▼    Structural characterization of proteins and enzymes isolated from organisms living under unusual conditions
▼    Caratterizzazione della famiglia proteica delle KCTD: fattori chiave in diversi processi biologici Characterization of the KCTD protein family: key factors in several biological processes
▼    Characterization of neurotoxic and neuroprotective factors by using computational methodologies
▼    Monoclonal Antibodies for therapeutic and diagnostic applications
▼    Targeted Drug Delivery by integrin avb3 antagonist
▼    Sintesi chimica e modificazione di proteine per applicazioni in campo biomedico Chemical protein synthesis and modification for biomedical applications
▼    Biomolecole in grado di modulare l’angiogenesi VEGF-dipendente Biomolecules able to modulate the VEGF-dependent angiogenesis
▼    Imaging Tumor Acidosis
▼    Bioactive peptide-membrane assemblies
No results. Nessun risultato.
▼    Carbonic Anhydrase IX as target for the development of new anti-tumour drugs L’Anidrasi Carbonica IX come target per lo sviluppo di nuovi farmaci antitumorali
▼    Carbonic Anhydrase family as target for rational drug design
▼    Clinical Oncology
▼    Translational Molecular Imaging in Cancer
▼    Molecular imaging for personalized therapy in oncology
▼    Modeling radiation induced normal tissue effects
▼    Evaluation of new molecular probes by preclinical imaging Test e validazione di nuove sonde molecolari mediante imaging preclinico
▼    Synthesis of small molecules, modified peptides and nucleobase-decorated peptides. Spectroscopic and computational investigation on the potential of natural product in biomedicine. Nucleic acid and protein binding studies Sintesi di small molecules, peptidi modificati e peptidi decorati con nucleobasi. Valutazione spettroscopica e computazionale del potenziale di prodotti naturali in biomedicina. Studi di interazione molecolare con acidi nucleici e proteine
▼    Brain segmentation for radiation oncology application Segmentazione cerebrale per applicazioni in radiologia oncologica
▼    Chemical modification of natural molecules, such as peptides and polysaccharides, to be employed as therapeutic agents as well as sensor diagnostic tools Modifiche chimiche eseguite su molecole naturali, quali peptide e polisaccaridi, e loro impiego come agenti terapeutici e sonde diagnostiche
▼    Drug discovery by mirror-image phage display Drug discovery attraverso l’impiego della tecnologia del mirror-image phage display
▼    Axl and Gas6 targeting for therapeutic and diagnostic applications Molecole che bersagliano Axl e Gas6 per applicazioni a scopo terapeutico e diagnostico
▼    Macromolecules for biomedical and biotechnological applications Macromolecole per applicazioni biomediche e biotecnologiche
▼    Protein-Protein-Interaction network–disease relationship, pathogenicity and therapeutic perspectives Relazione tra malattia e alterate interazioni proteina-proteina: patogenicità e prospettive terapeutiche
▼    A multi-targeting approach to fight COVID-19 Un approccio multi-targeting per combattere COVID-19
▼    Galectins: Structure, function and therapeutic potential inhibitors Galectine: struttura, funzione e potenziali inibitori terapeutici
▼    Caratterizzazione della famiglia proteica delle KCTD: fattori chiave in diversi processi biologici Characterization of the KCTD protein family: key factors in several biological processes
▼    Sintesi chimica e modificazione di proteine per applicazioni in campo biomedico Chemical protein synthesis and modification for biomedical applications
▼    Biomolecole in grado di modulare l’angiogenesi VEGF-dipendente Biomolecules able to modulate the VEGF-dependent angiogenesis
▼    Biomolecular NMR: structural studies of proteins and peptides and drug discovery applications Risonanza magnetica nucleare biomolecolare: studi strutturali di proteine e peptidi e applicazioni per il “drug discovery”
▼    Axl and Gas6 targeting for therapeutic and diagnostic applications Molecole che bersagliano Axl e Gas6 per applicazioni a scopo terapeutico e diagnostico
▼    Generation of innovative scaffolds by manipulating hyperstable proteins Design di scaffold innovativi mediante l’ingegnerizzazione di proteine termostabili
▼    The fine structure of proteins as a new tool for protein structure validation, quality assessment, and prediction La strutture fine delle proteine: un nuovo strumento per la validazione e la predizione della loro struttura tridimensionale
▼    Carbonic Anhydrase IX as target for the development of new anti-tumour drugs L’Anidrasi Carbonica IX come target per lo sviluppo di nuovi farmaci antitumorali
▼    Biochemical and functional characterization of intrinsically disordered proteins (IDPs) in human diseases Caratterizzazione biochimica e funzionale di proteine intrinsecamente disordinate e loro ruolo nelle malattie umane
▼    Biochemical and functional characterization of Protein-Protein and DNA-protein Interaction networks in physio/pathological events Caratterizzazione biochimica e funzionale di interazioni proteina-proteina e DNA-proteina in eventi fisio/patologici
▼    Biochemical and structural insights on Chromatin Assembly Factor 1 in physio/pathological events Studi biochimici e molecolari sul Fattore di Assemblaggio della Cromatina 1 coinvolta in eventi fisiopatologici
▼    Plant polypeptides as natural enhancers of biostimulation Polipeptidi vegetali come potenziatori naturali della biostimolazione
▼    Chemical modification of natural molecules, such as peptides and polysaccharides, to be employed as therapeutic agents as well as sensor diagnostic tools Modifiche chimiche eseguite su molecole naturali, quali peptide e polisaccaridi, e loro impiego come agenti terapeutici e sonde diagnostiche
▼    Protein-based biotherapeutics Bioterapeutici a base di proteine
▼    Understanding SARS-CoV-2 interaction with its host of for therapeutic applications Studi di interazioni patogeno-ospite in SARS-CoV-2
▼    Small molecules and peptides/modified peptides for diagnostic, therapeutic and biotechnological applications Piccole molecole e peptidi/peptidi modificati per applicazioni diagnostiche, terapeutiche e biotecnologiche
▼    Biomolecole in grado di modulare l’angiogenesi VEGF-dipendente Biomolecules able to modulate the VEGF-dependent angiogenesis
▼    New peptide–based molecules as NGF mimetics in the therapy of neurological dysfunctions Nuove molecole di natura peptidica che mimano l’NGF per la terapia di malattie neurologiche
▼    Peptide-based molecules for αvβ3 integrin modulation in Th17 cells-dependent demyelinating diseases Molecole di natura peptidica per modulare l’attività dell’integrina αvβ3 nelle malattie demielinizzanti Th17 dipendenti
▼    Development of integrin subtypes selective ligands: from a first rationally designed peptide to a wide range of molecules Sviluppo di ligandi selettivi per i sottotipi di integrine: dal primo peptide progettato su base razionale verso un ampio spettro di molecole
▼    Design of New FSHR-Specific Peptides for therapeutic and diagnostic applications Progettazione di nuovi peptidi specifici per il recettore dell’FSH per applicazioni diagnostiche e terapeutiche
▼    New synthetic molecules for active targeting of multifunctional theranostic nanosystems Nuove molecole sintetiche per il trasporto attivo di nanosistemi multifunzionali teranostici
▼    Biomolecular NMR: structural studies of proteins and peptides and drug discovery applications Risonanza magnetica nucleare biomolecolare: studi strutturali di proteine e peptidi e applicazioni per il “drug discovery”
▼    Galectins: Structure, function and therapeutic potential inhibitors Galectine: struttura, funzione e potenziali inibitori terapeutici
▼    Protein-Protein-Interaction network–disease relationship, pathogenicity and therapeutic perspectives Relazione tra malattia e alterate interazioni proteina-proteina: patogenicità e prospettive terapeutiche
▼    A multi-targeting approach to fight COVID-19 Un approccio multi-targeting per combattere COVID-19
▼    Axl and Gas6 targeting for therapeutic and diagnostic applications Molecole che bersagliano Axl e Gas6 per applicazioni a scopo terapeutico e diagnostico
▼    Drug discovery by mirror-image phage display Drug discovery attraverso l’impiego della tecnologia del mirror-image phage display
▼    Peptides of therapeutic interest with antimicrobial and/ or antitumoral activity Peptidi di interesse terapeutico con attività antimicrobica e/o antitumorale
▼    Analysis of Sam domain druggability through computational and experimental studies I domini Sam come bersagli farmacologici: studi computazionali e sperimentali
▼    Targeting Sam-Sam interactions mediated by EphA2 receptor: design and evaluation of peptide inhibitors Progettazione e validazione di peptidi inibitori delle interazioni Sam-Sam mediate dal recettore EphA2
▼    Synthesis of small molecules, modified peptides and nucleobase-decorated peptides. Spectroscopic and computational investigation on the potential of natural product in biomedicine. Nucleic acid and protein binding studies Sintesi di small molecules, peptidi modificati e peptidi decorati con nucleobasi. Valutazione spettroscopica e computazionale del potenziale di prodotti naturali in biomedicina. Studi di interazione molecolare con acidi nucleici e proteine
▼    Plant polypeptides as natural enhancers of biostimulation Polipeptidi vegetali come potenziatori naturali della biostimolazione
▼    Chemical modification of natural molecules, such as peptides and polysaccharides, to be employed as therapeutic agents as well as sensor diagnostic tools Modifiche chimiche eseguite su molecole naturali, quali peptide e polisaccaridi, e loro impiego come agenti terapeutici e sonde diagnostiche
▼    Design and screening of molecular repertoires as a source for new bioactive compounds Progettazione e screening di repertori molecolari come fonte di nuovi composti bioattivi
▼    Targeting Of Protein-Protein Interactions For Therapeutic Purposes Targeting delle interazioni proteina-proteina per scopi terapeutici
▼    Carbonic Anhydrase IX as target for the development of new anti-tumour drugs L’Anidrasi Carbonica IX come target per lo sviluppo di nuovi farmaci antitumorali
▼    Biochemical and functional characterization of intrinsically disordered proteins (IDPs) in human diseases Caratterizzazione biochimica e funzionale di proteine intrinsecamente disordinate e loro ruolo nelle malattie umane
▼    Biochemical and functional characterization of Protein-Protein and DNA-protein Interaction networks in physio/pathological events Caratterizzazione biochimica e funzionale di interazioni proteina-proteina e DNA-proteina in eventi fisio/patologici
▼    Biochemical and structural insights on Chromatin Assembly Factor 1 in physio/pathological events Studi biochimici e molecolari sul Fattore di Assemblaggio della Cromatina 1 coinvolta in eventi fisiopatologici
▼    Plant polypeptides as natural enhancers of biostimulation Polipeptidi vegetali come potenziatori naturali della biostimolazione
Empty curriculum Curriculum vuoto
Advanced search Ricerca avanzata▼
Content Contiene: [X]      Extended Estesa     Authors Autori: [X]  Paper type Tipo di lavoro: [X]   Start date Data iniziale: End date Data finale: [X]      Site Sede: IBB affiliation Affiliazione IBB     
    
[Clear form Pulisci modulo]
End of page Vai a fine pagina   Copy&Paste Friendly Versione per copia e incolla facile   Export all to Esporta tutto in BibTeX   Export all to Esporta tutto in EndNote

Publications Pubblicazioni
Sort by Ordina per:   date a ▼▲   title titolo ▲ ▼   journal rivista ▲ ▼   authors autori ▲ ▼   impact factor ▲ ▼
* Tc 99-Sesta Mibi Uptake In Nonsecretory Multiple Myeloma (305 views visite)
Catalano L, Andretta C, Pace L, Del Vecchio S, Salvatore B, De Rosa G, Buonanno MT, Paone G, Rotoli B
Hematology (ISSN: 1024-5332), 2005 Sep; 10(4): 335-338.
Impact Factor: 1.189
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* The Structural Comparison Between Membrane-Associated Human Carbonic Anhydrases Provides Insights Into Drug Design Of Selective Inhibitors (362 views visite)
Alterio V, Pan P, Parkkila S, Buonanno M, Supuran CT, Monti SM, De Simone G
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2014; 101(7): 769-778.
Impact Factor: 2.385
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* A virulence factor encoded by a polydnavirus confers tolerance to transgenic tobacco plants against lepidopteran larvae, by impairing nutrient absorption (361 views visite)
Di Lelio I, Caccia S, Coppola M, Buonanno M, Di Prisco G, Varricchio P, Franzetti E, Corrado G, Monti SM, Rao R, Casartelli M, Pennacchio F
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2014 Dec 1; 9(12): N/D-N/D.
Impact Factor: 3.234
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Out of the active site binding pocket for carbonic anhydrase inhibitors (336 views visite) (PDF 226 views visite)
D'Ambrosio K, Carradori S, Monti SM, Buonanno M, Secci D, Vullo D, Supuran CT, De Simone G
Chem Commun (ISSN: 1359-7345, 1364-548x, 1364-548xelectronic), 2015 Jan 7; 51(2): 302-305.
Impact Factor: 6.567
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Crystal structure of the most catalytically effective carbonic anhydrase enzyme known, SazCA from the thermophilic bacterium Sulfurihydrogenibium azorense (241 views visite)
De Simone G, Monti SM, Alterio V, Buonanno M, De Luca V, Rossi M, Carginale V, Supuran CT, Capasso C, Di Fiore A
Bioorg Med Chem Lett (ISSN: 0960-894x), 2015 May 1; 25(9): 2002-2006.
Impact Factor: 2.486
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/1, 3, 4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors (251 views visite)
Mishra CB, Kumari S, Angeli A, Monti SM, Buonanno M, Prakash A, Tiwari M, Supuran CT
J Enzyme Inhib Med Chem, 2016; 17: 1-6.
Impact Factor: 3.428
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Microwave-assisted extraction, HPLC analysis, and inhibitory effects on carbonic anhydrase I, II, VA, and VII isoforms of 14 blueberry Italian cultivars (205 views visite)
Mollica A, Locatelli M, Macedonio G, Carradori S, Sobolev AP, De Salvador RF, Monti SM, Buonanno M, Zengin G, Angeli A, Supuran CT
J Enzyme Inhib Med Chem, 2016; 31(sup4): N/D-N/D.
Impact Factor: 3.428
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Protein conformational perturbations in hereditary amyloidosis: Differential impact of single point mutations in ApoAI amyloidogenic variants (371 views visite)
Del Giudice R, Arciello A, Itri F, Merlino A, Monti M, Buonanno M, Penco A, Canetti D, Petruk G, Monti SM, Relini A, Pucci P, Piccoli R, Monti DM
Bba-Gen Subjects (ISSN: 0925-4439, 0006-3002, 1570-9639), 2016; 1860(2): 434-444.
Impact Factor: 5.476
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Evolution of protein bound Maillard reaction end-products and free Amadori compounds in low lactose milk in presence of fructosamine oxidase (284 views visite)
Troise AD, Buonanno M, Fiore A, Monti SM, Fogliano V
Food Chem (ISSN: 0308-8146, 0308-8146print), 2016 Dec 1; 212: 722-729.
Impact Factor: 4.529
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Discovery of 4-sulfamoyl-phenyl-β-lactams as a new class of potent carbonic anhydrase isoforms I, II, IV and VII inhibitors: The first example of subnanomolar CA IV inhibitors (211 views visite)
Angapelly S, Ramya PVS, Angeli A, Monti SM, Buonanno M, Alvala M, Supuran CT, Arifuddin M
Bioorg Med Chem (ISSN: 0968-0896, 1464-3391), 2017; 25(2): 539-544.
Impact Factor: 2.881
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Discovery of 4-sulfamoyl-phenyl-beta-lactams as a new class of potent carbonic anhydrase isoforms I, II, IV and VII inhibitors: The first example of subnanomolar CA IV inhibitors (268 views visite)
Angapelly S, Ramya PV, Angeli A, Monti SM, Buonanno M, Alvala M, Supuran CT, Arifuddin M
Bioorg Med Chem (ISSN: 0968-0896, 1464-3391), 2017 Jan 15; pii:S0968-0896(16): 539-544.
Impact Factor: 2.881
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Synthesis of isoxazole-containing sulfonamides with potent carbonic anhydrase II and VII inhibitory properties (247 views visite)
Altug C, Gunes H, Nocentini A, Monti SM, Buonanno M, Supuran CT
Bioorg Med Chem (ISSN: 0968-0896, 1464-3391), 2017 Feb 15; 25(4): 1456-1464.
Impact Factor: 2.881
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Discovery of Benzenesulfonamides with Potent Human Carbonic Anhydrase Inhibitory and Effective Anticonvulsant Action: Design, Synthesis, and Pharmacological Assessment (293 views visite)
Mishra CB, Kumari S, Angeli A, Monti SM, Buonanno M, Tiwari M, Supuran CT
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2017 Mar 23; 60(6): 2456-2469.
Impact Factor: 6.253
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Disclosing the Interaction of Carbonic Anhydrase IX with Cullin-Associated NEDD8-Dissociated Protein 1 by Molecular Modeling and Integrated Binding Measurements (236 views visite)
Buonanno M, Langella E, Zambrano N, Succoio M, Sasso E, Alterio V, Di Fiore A, Sandomenico A, Supuran CT, Scaloni A, Monti SM, De Simone G
Acs Chem Biol (ISSN: 1554-8929), 2017 Apr 19; N/D: N/D-N/D.
Impact Factor: 4.592
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Prosystemin, a prohormone that modulates plant defense barriers, is an intrinsically disordered protein (311 views visite)
Buonanno M, Coppola M, Di Lelio I, Molisso D, Leone M, Pennacchio F, Langella E, Rao R, Monti SM
Protein Sci (ISSN: 1469-896xelectronic, 0961-8368linking), 2018 Mar; 27(3): 620-632.
Impact Factor: 2.937
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* The Crystal Structure of a hCA VII Variant Provides Insights into the Molecular Determinants Responsible for Its Catalytic Behavior (220 views visite)
Buonanno M, Di Fiore A, Langella E, D’ambrosio K, Supuran CT, Monti SM, De Simone G
Int J Mol Sc (ISSN: 1661-6596, 1422-0067, 1422-0067electronic), 2018 May; 19(6): 19-24.
Impact Factor: 3.687
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Discovery of potent anti-convulsant carbonic anhydrase inhibitors: Design, synthesis, in vitro and in vivo appraisal (197 views visite)
Mishra CB, Kumari S, Angeli A, Bua S, Buonanno M, Monti SM, Tiwari M, Supuran CT
Eur J Med Chem (ISSN: 0223-5234linking, 1768-3254electronic), 2018 Aug 5; 156: 430-443.
Impact Factor: 4.816
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Biochemical, biophysical and molecular dynamics studies on the proteoglycan-like domain of carbonic anhydrase IX (280 views visite)
Langella E, Buonanno M, Vullo D, Dathan N, Leone M, Supuran C, De Simone G, Monti SM
Cell Mol Life Sci (ISSN: 1420-682xlinking), 2018 Sep; 75(17): 3283-3296.
Impact Factor: 6.721
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* The zinc - but not cadmium - containing zeta-carbonic from the diatom Thalassiosira weissflogii is potently activated by amines and amino acids (132 views visite)
Angeli A, Buonanno M, Donald WA, Monti SM, Supuran CT
Bioorg Chem (ISSN: 1090-2120electronic, 0045-2068linking), 2018 Oct; 80: 261-265.
Impact Factor: 3.929
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety (260 views visite)
Buemi MR, Di Fiore A, De Luca L, Angeli A, Mancuso F, Ferro S, Monti SM, Buonanno M, Russo E, De Sarro G, De Simone G, Supuran CT, Gitto R
Eur J Med Chem (ISSN: 1768-3254electronic, 0223-5234linking), 2019 Feb 1; 163: 443-452.
Impact Factor: 4.833
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Intrinsically disordered features of carbonic anhydrase IX proteoglycan-like domain (54 views visite)
Langella E, Buonanno M, De Simone G, Monti SM
Cell Mol Life Sci (ISSN: 1420-682xlinking), 2020; 21: 8405-8405.
Impact Factor: 6.496
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Phenyl(thio)phosphon(amid)ate Benzenesulfonamides as Potent and Selective Inhibitors of Human Carbonic Anhydrases II and VII Counteract Allodynia in a Mouse Model of Oxaliplatin-Induced Neuropathy (69 views visite)
Nocentini A, Alterio V, Bua S, Micheli L, Esposito D, Buonanno M, Bartolucci G, Osman SM, Alothman ZA, Cirilli R, Pierini M, Monti SM, Di Cesare Mannelli L, Gratteri P, Ghelardini C, De Simone G, Supuran CT
J Med Chem (ISSN: 0022-2623linking), 2020 May 28; 63(10): 5185-5200.
Impact Factor: 6.205
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Targeted somatic mutagenesis through CRISPR/Cas9 ribonucleoprotein complexes in the olive fruit fly, Bactrocera oleae (38 views visite)
Meccariello A, Tsoumani KT, Gravina A, Primo P, Buonanno M, Mathiopoulos KD, Saccone G
Arch Insect Biochem Physiol (ISSN: 0739-4462linking), 2020 Jun; 104(2): e21667-N/D.
Impact Factor: 1.28
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Biochemical and structural characterisation of a protozoan beta-carbonic anhydrase from Trichomonas vaginalis (87 views visite)
Urbański LJ, Di Fiore A, Azizi L, Hytönen VP, Kuuslahti M, Buonanno M, Monti SM, Angeli A, Zolfaghari Emameh R, Supuran CT, De Simone G, Parkkila S
J Enzyme Inhib Med Chem (ISSN: 1475-6366linking), 2020 Dec; 35(1): 1292-1299.
Impact Factor: 4.673
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* The crystal structures of 2-(4-benzhydrylpiperazin-1-yl)-N-(4-sulfamoylphenyl)acetamide in complex with human carbonic anhydrase II and VII provide insights into selective CA inhibitor development (50 views visite)
D’ambrosio K, Di Fiore A, Buonanno M, Kumari S, Tiwari M, Supuran CT, Mishra CB, Monti SM, De Simone G
New Journal Of Chemistry, 2021; 45: 147-152.
Impact Factor: 3.288
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote



25 Records (24 excluding Abstracts and Conferences escludendo Abstract e Conferenze).
Total impact factor Impact factor totale: 101.075 (97.841 excluding Abstracts and Conferences escludendo Abstract e Conferenze).
Total 5 year impact factor Impact factor a 5 anni totale: 83.389 (79.687 excluding Abstracts and Conferences escludendo Abstract e Conferenze).


Last modified by Ultima modifica di Gennaro Angrisano on in data Tuesday 05 May 2020, 22:03:32
1018 views visite. Last view on Ultima visita in data Friday 23 April 2021, 16:53:23